Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
Volume 306, Issue 7, Pages R490-R498
Publisher
American Physiological Society
Online
2014-01-30
DOI
10.1152/ajpregu.00495.2013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
- (2013) Jonathan E. Campbell et al. Cell Metabolism
- Comparative Effects of Prolonged and Intermittent Stimulation of the Glucagon-Like Peptide 1 Receptor on Gastric Emptying and Glycemia
- (2013) M. M. Umapathysivam et al. DIABETES
- Cardiovascular Biology of the Incretin System
- (2012) John R. Ussher et al. ENDOCRINE REVIEWS
- GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic MaleApoE−/−Mice
- (2012) Naim Panjwani et al. ENDOCRINOLOGY
- Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1
- (2012) David G Parkes et al. Expert Opinion on Drug Discovery
- Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice
- (2011) Benjamin J. Lamont et al. JOURNAL OF CLINICAL INVESTIGATION
- Discovery of Dual-Action Membrane-Anchored Modulators of Incretin Receptors
- (2011) Jean-Philippe Fortin et al. PLoS One
- The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats
- (2010) Que Liu et al. Cardiovascular Diabetology
- Pharmacokinetics and Pharmacodynamics of Exenatide Extended-Release After Single and Multiple Dosing
- (2010) Mark Fineman et al. CLINICAL PHARMACOKINETICS
- Glucagon-Like Peptide-1 Receptor Knockout Mice Are Protected from High-Fat Diet-Induced Insulin Resistance
- (2010) Julio E. Ayala et al. ENDOCRINOLOGY
- Exendin-4 has an anti-hypertensive effect in salt-sensitive mice model
- (2009) Kunio Hirata et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Differences in the Central Anorectic Effects of Glucagon-Like Peptide-1 and Exendin-4 in Rats
- (2009) Jason G. Barrera et al. DIABETES
- Glucagon-Like Peptide-1 Receptor Activation Modulates Pancreatitis-Associated Gene Expression But Does Not Modify the Susceptibility to Experimental Pancreatitis in Mice
- (2009) J. A. Koehler et al. DIABETES
- Insulin-like actions of glucagon-like peptide-1: a dual receptor hypothesis
- (2009) Eva Tomas et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now